Edurant ped and Tri lo sprintec drug interactions - a phase IV clinical study of FDA data
Summary:
We study 63 people who take Edurant ped (rilpivirine hydrochloride) and Tri lo sprintec (ethinyl estradiol; norgestimate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Edurant ped and Tri lo sprintec. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Edurant ped?
Edurant ped has active ingredients of rilpivirine hydrochloride.
What is Tri lo sprintec?
Tri lo sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 63 Tri lo sprintec users. Check the latest studies of Tri lo sprintec.
No report is found.
Do you take Edurant ped and Tri lo sprintec?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Edurant ped
- Tri lo sprintec (63 reports)
How the study uses the data?
The study uses data from the FDA. It is based on rilpivirine hydrochloride and ethinyl estradiol; norgestimate (the active ingredients of Edurant ped and Tri lo sprintec, respectively), and Edurant ped and Tri lo sprintec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Arthritis and Pleurisy - now
- Could Lexapro cause Vasogenic Cerebral Oedema? - a second ago
- Systemic Lupus Erythematosus and Compression Fracture - a second ago
- Granuloma and drugs of ingredients of aclidinium bromide - 4 seconds ago
- Symbicort and Colace drug interactions for women aged 30-39 - 4 seconds ago
- Could Spiriva Respimat cause Foetal Exposure During Pregnancy? - 7 seconds ago
- Could Navelbine cause Pharyngitis? - 7 seconds ago
- Drug interactions of Rebetol and Anafranil - 12 seconds ago
- Could Coumadin cause Prostate Infection? - 13 seconds ago
- Could Nasalcrom cause Balance Disorder? - 17 seconds ago